IGFBP-3 Methylation-Derived Deficiency Mediates the Resistance to Cisplatin Through the Activation of the IGFIR/Akt Pathway in Non-Small Cell Lung Cancer
Oncogene - United Kingdom
doi 10.1038/onc.2012.146
Full Text
Open PDFAbstract
Available in full text
Date
April 30, 2012
Authors
Publisher
Springer Science and Business Media LLC